Trials / Terminated
TerminatedNCT01367899
CONSERVE Plus Post-Approval Study (PAS)
Conserve Plus Total Hip Resurfacing System: A Non-Randomized, Multi-center, NewEnrollement Post Approval Study
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 199 (actual)
- Sponsor
- MicroPort Orthopedics Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this post-approval study is to provide scientifically valid and reliable evidence that supports claims of longer term safety and effectiveness with regard to Month 120 device survivorship rates.
Detailed description
This study will evaluate the performance of CONSERVE Plus Hip Resurfacing System under actual conditions of use. Additionally, this study will evaluate the performance of the device in the post approval environment to see if there are any significant changes in device performance as compared to the pre-market IDE Study
Conditions
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2011-06-07
- Last updated
- 2014-10-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01367899. Inclusion in this directory is not an endorsement.